Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome

A study reveals the involvement of the endocannabinoid system in cognitive disorders in mouse models of Down syndrome. The work identifies cannabinoid receptor type-1 (CB1) as a potential treatment target.

Leave a Reply

Your email address will not be published. Required fields are marked *